Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06141941 · ClinicalTrials.gov registry record · NA
Does the Use of Continuous Glucose Monitoring (CGM) in the Immediate Postpartum Period in Women With Pregestational Diabetes Admitted to the Hospital Decrease Hypoglycemic Episodes
A NA study of Pregestational Diabetes, sponsored by Andrea L. Greiner.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT06141941 is a NA study of Pregestational Diabetes that is actively recruiting participants, run by Andrea L. Greiner. The registered enrollment target is 40 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06141941, a NA study of Pregestational Diabetes, is actively recruiting participants, sponsored by Andrea L. Greiner.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will examine whether continuous glucose monitoring in patients hospitalized in the immediate postpartum period is more effective than traditional point of care glucose testing in identifying patients with hypoglycemia.
Conditions Studied
Interventions
- DEVICE CGM
Study Locations (1)
Iowa
- University of Iowa Hospitals and Clinics - Iowa City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2021-06-01 |
| Est. Completion | 2024-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06141941
The ClinicalTrials.gov registry entry for NCT06141941 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Andrea L. Greiner, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pregestational Diabetes appearing as the primary indexed condition, and to 1 intervention - of which CGM is the first listed.
NCT06141941 reports 1 study location spanning 1 distinct geographic area - top geographies include Iowa.
Frequently Asked Questions
What is clinical trial NCT06141941 about?
NCT06141941 is a clinical study titled "Does the Use of Continuous Glucose Monitoring (CGM) in the Immediate Postpartum Period in Women With Pregestational Diabetes Admitted to the Hospital Decrease Hypoglycemic Episodes". This study will examine whether continuous glucose monitoring in patients hospitalized in the immediate postpartum period is more effective than traditional point of care glucose testing in identifying patients with hypoglycemia.
What is the current status of trial NCT06141941?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2021-06-01. Estimated completion is 2024-04.
What conditions does trial NCT06141941 study?
This clinical trial studies the following conditions: Pregestational Diabetes.
What interventions are being tested in trial NCT06141941?
The interventions under investigation include: CGM (DEVICE).
Who is sponsoring clinical trial NCT06141941?
This trial is sponsored by Andrea L. Greiner, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06141941 being conducted?
This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.